Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.
Wolfe Research Initiates Coverage On Medtronic with Underperform Rating
Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.
Related Posts
Uber Finally Enters Cannabis Space In Canada, Adds Marijuana Orders Via Uber Eats In Ontario
Uber (NYSE: UBER) is getting into the cannabis industry in Canada!
SVB Leerink Maintains Market Perform on Solid Biosciences, Raises Price Target to $6
SVB Leerink analyst Joseph Schwartz maintains Solid Biosciences (NASDAQ:SLDB) with a Market Perform and raises the price target from $1 to $6.
OP Bancorp Q4 EPS $0.59 Up From $0.25 YoY
OP Bancorp (NASDAQ:OPBK) reported quarterly earnings of $0.59 per share. This is a 136 percent increase over earnings of $0.25 per share from the same period last year.